Exmceuticals Inc
F:9OM1
Income Statement
Earnings Waterfall
Exmceuticals Inc
Income Statement
Exmceuticals Inc
| Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||
| Operating Expenses |
(12)
|
(11)
|
(8)
|
(9)
|
(9)
|
(11)
|
(10)
|
|
| Selling, General & Administrative |
(4)
|
(5)
|
(6)
|
(7)
|
(8)
|
(10)
|
(10)
|
|
| Research & Development |
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(7)
|
(7)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Operating Income |
(12)
N/A
|
(11)
+1%
|
(8)
+28%
|
(9)
-5%
|
(9)
-10%
|
(11)
-11%
|
(10)
+0%
|
|
| Pre-Tax Income | ||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
0
|
(0)
|
(0)
|
(1)
|
0
|
(1)
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
|
| Pre-Tax Income |
(12)
N/A
|
(12)
-4%
|
(9)
+22%
|
(10)
-6%
|
(10)
-5%
|
(13)
-21%
|
(12)
+4%
|
|
| Net Income | ||||||||
| Income from Continuing Operations |
(12)
|
(12)
|
(9)
|
(10)
|
(10)
|
(13)
|
(12)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Net Income (Common) |
(11)
N/A
|
(12)
-3%
|
(9)
+24%
|
(9)
-4%
|
(10)
-7%
|
(12)
-24%
|
(12)
+3%
|
|
| EPS (Diluted) |
-0.28
N/A
|
-0.31
-11%
|
-0.23
+26%
|
-0.23
N/A
|
-0.15
+35%
|
-0.16
-7%
|
-0.15
+6%
|
|